346 related articles for article (PubMed ID: 6327814)
1. Glycoproteins of 210,000 and 130,000 m.w. on activated T cells: cell distribution and antigenic relation to components on resting cells and T cell lines.
Hemler ME; Sanchez-Madrid F; Flotte TJ; Krensky AM; Burakoff SJ; Bhan AK; Springer TA; Strominger JL
J Immunol; 1984 Jun; 132(6):3011-8. PubMed ID: 6327814
[TBL] [Abstract][Full Text] [Related]
2. Characterization of a novel differentiation antigen complex recognize by a monoclonal antibody (A-1A5): unique activation-specific molecular forms on stimulated T cells.
Hemler ME; Ware CF; Strominger JL
J Immunol; 1983 Jul; 131(1):334-40. PubMed ID: 6408178
[TBL] [Abstract][Full Text] [Related]
3. Identification of several cell surface proteins of non-T, non-B acute lymphoblastic leukemia by using monoclonal antibodies.
Quackenbush EJ; Letarte M
J Immunol; 1985 Feb; 134(2):1276-85. PubMed ID: 3155538
[TBL] [Abstract][Full Text] [Related]
4. Identification of a human endothelial cell antigen with monoclonal antibody 44G4 produced against a pre-B leukemic cell line.
Gougos A; Letarte M
J Immunol; 1988 Sep; 141(6):1925-33. PubMed ID: 3262644
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibody SN2 defining a human T cell leukemia-associated cell surface glycoprotein.
Seon BK; Negoro S; Barcos MP; Tebbi CK; Chervinsky D; Fukukawa T
J Immunol; 1984 Apr; 132(4):2089-95. PubMed ID: 6607954
[TBL] [Abstract][Full Text] [Related]
6. Lymphocyte activation antigens. I. A monoclonal antibody, anti-Act I, defines a new late lymphocyte activation antigen.
Lazarovits AI; Moscicki RA; Kurnick JT; Camerini D; Bhan AK; Baird LG; Erikson M; Colvin RB
J Immunol; 1984 Oct; 133(4):1857-62. PubMed ID: 6088627
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibodies, L-35 and L-36, define novel T cell activation antigens.
Maino VC; Janszen ME
J Immunol; 1986 Nov; 137(10):3093-9. PubMed ID: 3095423
[TBL] [Abstract][Full Text] [Related]
8. Characterization of an antigen expressed on activated human T cells and platelets.
Brashem-Stein C; Nugent D; Bernstein ID
J Immunol; 1988 Apr; 140(7):2330-3. PubMed ID: 2832474
[TBL] [Abstract][Full Text] [Related]
9. Preparation and characterization of monoclonal antibodies reactive with porcine PBL.
Pescovitz MD; Lunney JK; Sachs DH
J Immunol; 1984 Jul; 133(1):368-75. PubMed ID: 6609988
[TBL] [Abstract][Full Text] [Related]
10. Preparation and characterization of monoclonal antibodies recognizing three distinct differentiation antigens (BL1, BL2, BL3) on human B lymphocytes.
Wang CY; Azzo W; Al-Katib A; Chiorazzi N; Knowles DM
J Immunol; 1984 Aug; 133(2):684-91. PubMed ID: 6429242
[TBL] [Abstract][Full Text] [Related]
11. Ta1, a novel 105 KD human T cell activation antigen defined by a monoclonal antibody.
Fox DA; Hussey RE; Fitzgerald KA; Acuto O; Poole C; Palley L; Daley JF; Schlossman SF; Reinherz EL
J Immunol; 1984 Sep; 133(3):1250-6. PubMed ID: 6205075
[TBL] [Abstract][Full Text] [Related]
12. Differential localization within human kidney of five membrane proteins expressed on acute lymphoblastic leukemia cells.
Quackenbush EJ; Gougos A; Baumal R; Letarte M
J Immunol; 1986 Jan; 136(1):118-24. PubMed ID: 2415610
[TBL] [Abstract][Full Text] [Related]
13. A novel glycoprotein expressed on sheep T and B lymphocytes is involved in a T cell activation pathway.
Hein WR; McClure S; Beya MF; Dudler L; Trnka Z
J Immunol; 1988 May; 140(9):2869-75. PubMed ID: 2834446
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibodies against human myelomonocytic cells: detection of certain lineage-specific antigens on CFU-GM progenitor cells.
Takaishi M; Fu SM
J Immunol; 1985 Aug; 135(2):1523-9. PubMed ID: 2409154
[TBL] [Abstract][Full Text] [Related]
15. Characterization of human interleukin 2 receptor (Tac antigen) in normal and leukemic T cells: co-expression of normal and aberrant receptors on Hut-102 cells.
Wano Y; Uchiyama T; Fukui K; Maeda M; Uchino H; Yodoi J
J Immunol; 1984 Jun; 132(6):3005-10. PubMed ID: 6327813
[TBL] [Abstract][Full Text] [Related]
16. A novel T cell activation antigen identified by monoclonal IMN3.1 antibody and expressed preferentially on human T cells susceptible to apoptotic cell death.
Uehara T; Miyawaki T; Natsuume-Sakai S; Nibu R; Hasui M; Yachie A; Shimizu S; Taniguchi N
J Immunol; 1993 Apr; 150(8 Pt 1):3243-53. PubMed ID: 7682236
[TBL] [Abstract][Full Text] [Related]
17. MALA-1: a surface antigen expressed on activated murine T and B lymphocytes.
Takei F
J Immunol; 1984 Jul; 133(1):345-50. PubMed ID: 6609986
[TBL] [Abstract][Full Text] [Related]
18. Use of the monoclonal antibody 12F1 to characterize the differentiation antigen VLA-2.
Pischel KD; Hemler ME; Huang C; Bluestein HG; Woods VL
J Immunol; 1987 Jan; 138(1):226-33. PubMed ID: 3023488
[TBL] [Abstract][Full Text] [Related]
19. Properties of a surface antigen expressed on activated human thymus-derived lymphocytes.
Udey MC; Jendrisak MD; Parker CW
J Immunol; 1982 Apr; 128(4):1870-5. PubMed ID: 6801123
[TBL] [Abstract][Full Text] [Related]
20. Two surface antigens expressed on proliferating mouse T lymphocytes defined by rat monoclonal antibodies.
Takei F
J Immunol; 1983 Jun; 130(6):2794-7. PubMed ID: 6304191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
